account* Merck, Roche reach nonexclusive deal on hepatitis drugs * Companies decline to provide financial terms * Analyst says deal may unfairly thwart rival Vertex drug (Adds details of deal, analyst concerns...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to UPDATE 1-Merck,Roche forge hepatitis C sales, research deal
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account